amino retatrutide π (Reta) is a synthetic peptide-based drug composed of 39 acids. It was developed by Eli Lilly and is being studied extensively as a treatment for obesity and metabolic diseases Reta (RUO) | GIP/GLP-1/GCG Agonist
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12

















![The Science Behind MindBody GLP-1 System [US-EN]](https://i.ytimg.com/vi/aTeZNdiLo3g/hqdefault.jpg)









